DT-PACE

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Hazard-Bot (talk | contribs) at 19:39, 7 March 2016 (Bot: Adding {{Research help|Med}}; please leave feedback/comments at Wikipedia talk:Research help #ResHelp). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

DT-PACE refers to a chemotherapy regimen for multiple myeloma consisting of Dexamethasone, Thalidomide, Cisplatin or Platinol, Adriamycin or doxorubicin, Cyclophosphamide, and Etoposide. [1]

References

Template:Research help

  1. ^ DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma.

External links

Stub icon

This oncology article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=DT-PACE&oldid=708818128"